The effectiveness of hyaluronic acid in reducing adverse effects associated with inhaled hypertonic saline therapy in patients with cystic fibrosis: A systematic review and meta-analysis

BACKGROUND: Inhaled hypertonic saline (HS) is an effective mucolytic agent in patients with cystic fibrosis (CF). However, adverse events can impair the clinical utility of hypertonic saline (HS) in this patient population. In this study, we aimed to investigate the effectiveness of hyaluronic acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Arshid, Sana, Ullah, *Saad Ehsan, Imran, Junaid, Syed, Meeran Asher, Choradia, Aakash, Gousy, Nicole, Boparai, Sukhman, Shoaib, Mudassir, Shah, Bidhan Bikram, Netha, Aadarsh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Society of Respiratory Therapists 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621800/
https://www.ncbi.nlm.nih.gov/pubmed/37927455
http://dx.doi.org/10.29390/001c.89093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621800/
https://www.ncbi.nlm.nih.gov/pubmed/37927455
http://dx.doi.org/10.29390/001c.89093

Ejemplares similares